Last reviewed · How we verify
NCT06358196: CESAH
Complex Exploratory Study of Alcohol-Associated Hepatitis
trial in Alcoholic Hepatitis in 100 participants. Not yet recruiting.
30 April 2025
Quick facts
| Lead sponsor | Pavol Jozef Safarik University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 May 2024 |
| Primary completion | 30 April 2025 |
| Estimated completion | 30 April 2026 |
| Sites | 1 location across Slovakia |
Conditions studied
- Alcoholic Hepatitis — all drugs for Alcoholic Hepatitis →
Sponsor
Pavol Jozef Safarik University
Who can join
18 and older, any sex, with Alcoholic Hepatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Alcohol-associated hepatitis is a clinical syndrome distinct from steatohepatitis or liver cirrhosis. It is associated with high mortality and characterized by an absence of effective treatment, while corticosteroids, which are currently used as the first-line treatment are effective only in a subpopulation of patients and only on 28-days survival - their effect on survival does not last beyond this interval. The proposed study is a complex exploratory study of alcohol-associated hepatitis with several epidemiology- and prognosis-related aims.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06358196
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcoholic Hepatitis
Currently open trials in the same condition.
- NCT06919458 — Short Course Steroids in Alcohol Associated Hepatitis · Phase 3 · recruiting
- NCT06307964 — Intra-Hepatic Microbiota in Alcoholic Hepatitis · recruiting
- NCT05006430 — Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis · Phase 1, PHASE2 · recruiting
- NCT05018481 — HA35 Moderate Alcoholic Hepatitis (AH) Study · EARLY_PHASE1 · recruiting
- NCT02473341 — Gut-Liver Axis Modulation With IgG-Enriched Immunotherapy in Severe Alcohol-Associated Hepatitis · Phase 3 · active not recruiting
Other Pavol Jozef Safarik University trials
Trials by the same sponsor.
- NCT07491068 — The Accuracy and Efficacy of Large Language Model Written Hospital Course Summaries · NA · not yet recruiting
- NCT03916666 — Chronic Low Back Pain - Epiduroscopy Treatment · unknown
- NCT03105232 — Opioid-Redox Study · unknown
- NCT05051176 — Prevalence of Diastasis m. Rectus Abdominis in Postpartum Women · completed
- NCT03915301 — Effective Postoperative Pain Treatment After Sternotomy. Comparison of the Erector Spinae Plane Block vs Conventional Op · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06358196 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pavol Jozef Safarik University
- Last refreshed: 10 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06358196.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing